Japan’s MHLW approves Boehringer’s Jascayd for IPF and PPF
The approval is based on Phase III FIBRONEER-IPF and FIBRONEER-ILD clinical trials conducted in parallel.
Drug Development
FDA approves Enhertu for two HER2-positive early breast cancer indications
Arna Pharma and Slate Run complete JV for new US company
Kyowa Kirin secures FDA approval for Crysvita dosing update
Zydus to acquire Assertio in $166m deal
Coya Therapeutics secures FDA fast track status for COYA 302
Pfizer receives EC approval for Hympavzi to treat haemophilia
UAE approves AstraZeneca’s Baxfendy for hypertension
